Patents by Inventor James F. List

James F. List has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating obesity employing an SGLT2 inhibitor
    Patent number: 8883743
    Abstract: Methods are provided for treating obesity or causing weight loss in a mammalian subject or patient, wherein a therapeutically effective amount of an SGLT2 inhibitor alone or optionally in combination with another anti-obesity agent, is administered to a mammalian subject or patient. In addition, a pharmaceutical composition is provided which comprises an SGLT2 inhibitor, alone or in combination with another anti-obesity agent, and a pharmaceutically acceptable carrier thereof.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: November 11, 2014
    Assignee: AstraZeneca AB
    Inventors: William Washburn, Jean Whaley, Mario Maidonado, James F. List, Frederick T. Fiedorek
  • USE OF GLP-1, GLP-1 DERIVATIVES OR GLP-1 FRAGMENTS FOR SKIN REGENERATION, STIMULATION OF HAIR GROWTH, OR TREATMENT OF DIABETES
    Publication number: 20120101038
    Abstract: The present invention relates to the use of GLP-I, GLP-I derivatives or GLP-I fragments for skin regeneration or hair growth in mammals. As used for skin regeneration, GLP-I, GLP-I derivatives or GLP-I fragments can be applied to dermal wounds including burns, lacerations, cuts and scrapes. As used for hair growth, GLP-I, GLP-I derivatives or GLP-I fragments can be applied to humans suffering from alopecia, or baldness. GLP-I, GLP-I derivatives or GLP-I fragments can also be used to stimulate hair growth in animals raised for their pelts. GLP-I, GLP-I derivatives or GLP-I fragments can also be used in the redifferentiation of endothelial or skin cells into insulin producing cells, as a treatment for patients suffering from diabetes.
    Type: Application
    Filed: September 2, 2011
    Publication date: April 26, 2012
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Joel F. Habener, James F. List, Svetlana Mojsov
  • METHODS FOR TREATING OBESITY EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITIONS THEREOF
    Publication number: 20120077739
    Abstract: Methods are provided for treating obesity or causing weight loss in a mammalian subject or patient, wherein a therapeutically effective amount of an SGLT2 inhibitor alone or optionally in combination with another anti-obesity agent, is administered to a mammalian subject or patient. In addition, a pharmaceutical composition is provided which comprises an SGLT2 inhibitor, alone or in combination with another anti-obesity agent, and a pharmaceutically acceptable carrier thereof.
    Type: Application
    Filed: December 2, 2011
    Publication date: March 29, 2012
    Applicant: BRISTOL-MYERS SQUIBB
    Inventors: William Washburn, Jean Whaley, Mario Maldonado, James F. List, Frederick T. Fiedorek
  • Methods for treating obesity employing an SGLT2 inhibitor
    Patent number: 8088743
    Abstract: Methods are provided for treating obesity or causing weight loss in a mammalian subject or patient, wherein a therapeutically effective amount of an SGLT2 inhibitor alone or optionally in combination with another anti-obesity agent, is administered to a mammalian subject or patient. In addition, a pharmaceutical composition is provided which comprises an SGLT2 inhibitor, alone or in combination with another anti-obesity agent, and a pharmaceutically acceptable carrier thereof.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: January 3, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: William N. Washburn, Jean Whaley, Mario Maldonado, James F. List, Frederick T. Fiedorek
  • USE OF GLP-1, GLP-1 DERIVATIVES OR GLP-1 FRAGMENTS FOR SKIN REGENERATION, STIMULATION OF HAIR GROWTH, OR TREATMENT OF DIABETES
    Publication number: 20090202497
    Abstract: The present invention relates to the use of GLP-I, GLP-I derivatives or GLP-I fragments for skin regeneration or hair growth in mammals. As used for skin regeneration, GLP-I, GLP-I derivatives or GLP-I fragments can be applied to dermal wounds including burns, lacerations, cuts and scrapes. As used for hair growth, GLP-I, GLP-I derivatives or GLP-I fragments can be applied to humans suffering from alopecia, or baldness. GLP-I, GLP-I derivatives or GLP-I fragments can also be used to stimulate hair growth in animals raised for their pelts. GLP-I, GLP-I derivatives or GLP-I fragments can also be used in the redifferentiation of endothelial or skin cells into insulin producing cells, as a treatment for patients suffering from diabetes.
    Type: Application
    Filed: August 22, 2006
    Publication date: August 13, 2009
    Applicant: The General Hospital Corporation
    Inventors: Joel F. Habener, James F. List, Svetlana Mojsov
  • Methods for Treating Obesity Employing an SGLT2 Inhibitor and Compositions Thereof
    Publication number: 20080234367
    Abstract: Methods are provided for treating obesity or causing weight loss in a mammalian subject or patient, wherein a therapeutically effective amount of an SGLT2 inhibitor alone or optionally in combination with another anti-obesity agent, is administered to a mammalian subject or patient. In addition, a pharmaceutical composition is provided which comprises an SGLT2 inhibitor, alone or in combination with another anti-obesity agent, and a pharmaceutically acceptable carrier thereof.
    Type: Application
    Filed: March 21, 2008
    Publication date: September 25, 2008
    Applicant: BRISTOL-MYERS SQUIBB
    Inventors: William N. Washburn, Jean Whaley, Mario Maldonado, James F. List, Frederick T. Fiedorek